KR100723847B1 - 2,3-디히드로-6-니트로이미다조[2,1-ｂ]옥사졸 - Google Patents

2,3-디히드로-6-니트로이미다조[2,1-ｂ]옥사졸 Download PDF

Info

Publication number
KR100723847B1
KR100723847B1 KR1020057004567A KR20057004567A KR100723847B1 KR 100723847 B1 KR100723847 B1 KR 100723847B1 KR 1020057004567 A KR1020057004567 A KR 1020057004567A KR 20057004567 A KR20057004567 A KR 20057004567A KR 100723847 B1 KR100723847 B1 KR 100723847B1
Authority
KR
South Korea
Prior art keywords
group
substituted
halogen
unsubstituted
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1020057004567A
Other languages
English (en)
Korean (ko)
Other versions
KR20050061473A (ko
Inventor
히데츠구 츠보우치
히로후미 사사키
히데아키 구로다
모토히로 이토타니
다케시 하세가와
요시카즈 하라구치
다케시 구로다
다카유키 마츠자키
다츠오 도미시게
구니노리 다이
마코토 고마츠
마코토 마츠모토
히로유키 하시즈메
유지 세이케
마사노리 가와사키
다쿠미 스미다
신 미야무라
Original Assignee
오쓰까 세이야꾸 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 오쓰까 세이야꾸 가부시키가이샤 filed Critical 오쓰까 세이야꾸 가부시키가이샤
Publication of KR20050061473A publication Critical patent/KR20050061473A/ko
Application granted granted Critical
Publication of KR100723847B1 publication Critical patent/KR100723847B1/ko
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/20—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
KR1020057004567A 2002-10-11 2003-10-10 2,3-디히드로-6-니트로이미다조[2,1-ｂ]옥사졸 Expired - Lifetime KR100723847B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002298259 2002-10-11
JPJP-P-2002-00298259 2002-10-11

Publications (2)

Publication Number Publication Date
KR20050061473A KR20050061473A (ko) 2005-06-22
KR100723847B1 true KR100723847B1 (ko) 2007-05-31

Family

ID=32089299

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020057004567A Expired - Lifetime KR100723847B1 (ko) 2002-10-11 2003-10-10 2,3-디히드로-6-니트로이미다조[2,1-ｂ]옥사졸

Country Status (26)

Country Link
US (1) US7262212B2 (enExample)
EP (2) EP1555267B1 (enExample)
JP (1) JP4186065B2 (enExample)
KR (1) KR100723847B1 (enExample)
CN (4) CN102532162B (enExample)
AR (4) AR041198A1 (enExample)
AU (1) AU2003272979B2 (enExample)
BE (1) BE2014C053I2 (enExample)
BR (1) BRPI0314344B8 (enExample)
CA (1) CA2497569C (enExample)
CY (2) CY1113578T1 (enExample)
DK (1) DK1555267T3 (enExample)
ES (1) ES2400179T3 (enExample)
FR (1) FR14C0066I2 (enExample)
HU (1) HUS1400046I1 (enExample)
LU (1) LU92517I2 (enExample)
MX (1) MXPA05003674A (enExample)
MY (1) MY139244A (enExample)
PL (3) PL217919B1 (enExample)
PT (1) PT1555267E (enExample)
RU (1) RU2326121C3 (enExample)
SI (1) SI1555267T1 (enExample)
TW (1) TWI347946B (enExample)
UA (1) UA83200C2 (enExample)
WO (1) WO2004033463A1 (enExample)
ZA (1) ZA200501033B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101191072B1 (ko) 2007-05-08 2012-10-15 오쓰까 세이야꾸 가부시키가이샤 에폭시 화합물 및 이의 제조 방법

Families Citing this family (82)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60144284D1 (de) 2000-11-01 2011-05-05 Millennium Pharm Inc Stickstoffhaltige heterozyklische verbindungen und verfahren zu deren herstellung
TW200838855A (en) * 2002-10-15 2008-10-01 Otsuka Pharma Co Ltd Method for preparing 1-substituted-4-nitroimidazole compound
JP4761756B2 (ja) * 2003-10-31 2011-08-31 大塚製薬株式会社 ２，３−ジヒドロイミダゾ［２，１−ｂ］オキサゾ−ル化合物
SI1678185T1 (sl) 2003-10-31 2009-02-28 Otsuka Pharma Co Ltd Spojine 2,3-dihidro-6-nitroimidazo (2,1-b) oksazol za zdravljenje tuberkuloze
TWI300409B (en) 2004-02-18 2008-09-01 Otsuka Pharma Co Ltd Method for producing 4-nitroimidazole compound
WO2005095380A1 (ja) 2004-03-31 2005-10-13 Nippon Soda Co., Ltd. 環状アミン化合物および有害生物防除剤
JP4789966B2 (ja) * 2004-04-09 2011-10-12 大塚製薬株式会社 医薬組成物
JP4787529B2 (ja) * 2004-04-09 2011-10-05 大塚製薬株式会社 医薬組成物
CA2609957A1 (en) * 2005-06-20 2007-01-04 Schering Corporation Carbon-linked substituted piperidines and derivatives thereof useful as histamine h3 antagonists
PL1906926T3 (pl) * 2005-07-28 2011-04-29 Otsuka Pharma Co Ltd Kompozycja farmaceutyczna zawierająca pochodne 2,3-dihydro-6-nitroimidazo[2,1-B]oksazolu
JP5105818B2 (ja) * 2005-10-05 2012-12-26 大塚製薬株式会社 医薬組成物
TW201233389A (en) * 2005-10-05 2012-08-16 Otsuka Pharma Co Ltd Antituberculous therapeutic drugs and kit containing the same
EP1932844B1 (en) 2005-10-06 2015-09-02 Nippon Soda Co., Ltd. Cross-linked cyclic amine compounds and agents for pest control
TW200800268A (en) * 2005-11-04 2008-01-01 Otsuka Pharma Co Ltd Medicinal composition showing improved drug absorbability
CA2636929A1 (en) 2005-12-21 2007-07-12 Decode Genetics, Ehf Biaryl nitrogen heterocycle inhibitors of lta4h for treating inflammation
JP2009526773A (ja) * 2006-02-13 2009-07-23 ラボラトワール セローノ ソシエテ アノニム 細菌感染症治療のためのスルホンアミド誘導体
JP2007297305A (ja) * 2006-04-28 2007-11-15 Daiso Co Ltd Ｎ−（２，３−エポキシ−２−メチルプロピル）フタルイミドの製造法
US8835426B2 (en) * 2007-02-26 2014-09-16 Vitae Pharmaceuticals, Inc. Cyclic urea and carbamate inhibitors of 11β-hydroxysteroid dehydrogenase 1
JP5451611B2 (ja) * 2007-07-26 2014-03-26 ヴァイティー ファーマシューティカルズ，インコーポレイテッド １１β−ヒドロキシステロイドデヒドロゲナーゼ１のサイクリックインヒビター
PE20090595A1 (es) * 2007-08-15 2009-06-06 Glaxo Group Ltd Derivados de quinoliniloxipiperidina y pirrolidina como antagonistas del receptor h1
US20100222349A1 (en) * 2007-10-16 2010-09-02 Glaxo Group Limited Quinoline derivatives used to treat inflammatory and allergic diseases
AR069207A1 (es) * 2007-11-07 2010-01-06 Vitae Pharmaceuticals Inc Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
CA2708303A1 (en) 2007-12-11 2009-06-18 Vitae Pharmaceuticals, Inc. Cyclic urea inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
TW200934490A (en) * 2008-01-07 2009-08-16 Vitae Pharmaceuticals Inc Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
WO2009094169A1 (en) 2008-01-24 2009-07-30 Vitae Pharmaceuticals, Inc. Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CA2714532A1 (en) * 2008-02-11 2009-08-20 Vitae Pharmaceuticals, Inc. 1,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1
US8598160B2 (en) * 2008-02-15 2013-12-03 Vitae Pharmaceuticals, Inc. Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
CA2718264A1 (en) * 2008-03-18 2009-09-24 Vitae Pharmaceuticals, Inc. Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
CN101965353B (zh) * 2008-03-26 2014-12-17 丹诺医药(苏州）有限公司 共价连接到取代苯基噁唑烷酮的双环硝基咪唑类
KR20110002492A (ko) 2008-05-01 2011-01-07 비타이 파마슈티컬즈, 인코포레이티드 11베타-하이드록시스테로이드 탈수소효소 1의 고리형 억제제
TW201004945A (en) 2008-05-01 2010-02-01 Vitae Pharmaceuticals Inc Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
EP2291370B1 (en) 2008-05-01 2013-11-27 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
CA2723032A1 (en) * 2008-05-01 2009-11-05 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
WO2010011314A1 (en) 2008-07-25 2010-01-28 Boehringer Ingelheim International Gmbh Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1
US8846668B2 (en) 2008-07-25 2014-09-30 Vitae Pharmaceuticals, Inc. Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
US9643922B2 (en) 2008-08-18 2017-05-09 Yale University MIF modulators
MX2011001872A (es) * 2008-08-18 2011-05-23 Univ Yale Moduladores de mif.
US9540322B2 (en) 2008-08-18 2017-01-10 Yale University MIF modulators
WO2010143007A1 (en) * 2009-06-10 2010-12-16 Dynamit Nobel Gmbh Explosivstoff-Und Systemtechnik Method for the production of 2-halogeno-4-nitroimidazole
JP5525515B2 (ja) * 2008-08-21 2014-06-18 デイナミート ノーベル ゲゼルシャフト ミット ベシュレンクテル ハフツング エクスプロジーフシュトッフ− ウント ジステームテヒニク ２−ハロ−４−ニトロイミダゾール及びその中間体の製造方法
JP5679997B2 (ja) 2009-02-04 2015-03-04 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング １１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状阻害剤
TW201039034A (en) * 2009-04-27 2010-11-01 Chunghwa Picture Tubes Ltd Pixel structure and the method of forming the same
UA109255C2 (ru) 2009-04-30 2015-08-10 Берінгер Інгельхайм Інтернешнл Гмбх Циклические ингибиторы 11бета-гидроксистероиддегидрогеназы 1
KR20120061771A (ko) * 2009-04-30 2012-06-13 비타이 파마슈티컬즈, 인코포레이티드 11베타-하이드록시스테로이드 탈수소효소 1의 고리형 억제제
WO2011011123A1 (en) 2009-06-11 2011-01-27 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
WO2011002910A1 (en) 2009-07-01 2011-01-06 Vitae Pharmaceuticals, Inc. Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
RU2542988C2 (ru) * 2009-07-31 2015-02-27 Глоубал Элаенс Фор Тб Драг Дивелопмент Нитроимидазооксазины и их применения при противотуберкулезной терапии
NZ598165A (en) * 2009-07-31 2013-05-31 Global Alliance For Tb Drug Dev Nitroimidazooxazine and nitroimidazooxazole analogues and their uses
US9198913B2 (en) 2009-07-31 2015-12-01 Global Alliance For Tb Drug Development Nitroimidazooxazines and their uses in anti-tubercular therapy
EP2495563A4 (en) 2009-10-26 2013-04-10 Fujifilm Ri Pharma Co Ltd Diagnostic agent for infectious diseases
TW201200523A (en) * 2010-01-29 2012-01-01 Otsuka Pharma Co Ltd Synthetic intermediate of oxazole compound and method for producing the same
GB201012209D0 (en) * 2010-05-31 2010-09-08 Ge Healthcare Ltd In vivo imaging agent
EP2582698B1 (en) 2010-06-16 2016-09-14 Vitae Pharmaceuticals, Inc. Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
WO2011161128A1 (en) 2010-06-25 2011-12-29 Boehringer Ingelheim International Gmbh Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders
CA2813671A1 (en) 2010-11-02 2012-05-10 Boehringer Ingelheim International Gmbh Pharmaceutical combinations for the treatment of metabolic disorders
US9051333B2 (en) 2011-04-15 2015-06-09 Otsuka Pharmaceutical Co., Ltd. 6,7-dihydroimidazo [2,1-b] [1,3]oxazine bactericides
JP2015006994A (ja) * 2011-10-28 2015-01-15 大正製薬株式会社 ジヒドロイミダゾオキサゾール誘導体
US9572809B2 (en) 2012-07-18 2017-02-21 Spero Trinem, Inc. Combination therapy to treat Mycobacterium diseases
FR3000064A1 (fr) * 2012-12-21 2014-06-27 Univ Lille Ii Droit & Sante Composes de type spiroisoxazoline ayant une activite potentialisatrice de l'activite d'un antibiotique-composition et produit pharmaceutiques comprenant de tels composes
IN2013DE02954A (enExample) 2013-10-04 2015-04-10 Council Scient Ind Res
CN103524492A (zh) * 2013-10-23 2014-01-22 中国药科大学 侧链含硝基咪唑基团取代的喹诺酮类化合物、其制备及用途
TWI687409B (zh) 2014-08-28 2020-03-11 日商大塚製藥股份有限公司 稠合雜環化合物
JP6467042B2 (ja) * 2014-10-21 2019-02-06 カウンシル オブ サイエンティフィック アンド インダストリアル リサーチ 抗マイコバクテリア剤としての置換１，２，３−トリアゾール−１−イル−メチル−２，３−ジヒドロ−２−メチル−６−ニトロイミダゾ［２，１−ｂ］オキサゾールとその調製方法
CN105732659B (zh) * 2014-12-12 2019-07-16 上海阳帆医药科技有限公司 硝基咪唑类化合物及其制备方法和在制药中的用途
EP3252059A4 (en) * 2015-01-29 2018-07-11 Medshine Discovery Inc. Anti-pulmonary tuberculosis nitroimidazole derivative
KR102597449B1 (ko) 2015-03-27 2023-11-03 오츠카 세이야쿠 가부시키가이샤 1-(4-히드록시페닐)-4-(4-트리플루오로메톡시페녹시)피페리딘 또는 그 염의 제조방법
CN106317072B (zh) * 2015-06-17 2020-03-17 盟科医药技术(上海)有限公司 用于分枝杆菌感染治疗的杂环化合物及其应用
US10851079B2 (en) 2016-02-26 2020-12-01 Otsuka Pharmaceutical Co., Ltd. Piperidine derivative
CN105859628B (zh) * 2016-04-19 2018-08-07 清远职业技术学院 一种抗菌化合物对n咪唑苯甲醛缩邻甲苯胺希夫碱及其制备方法和应用
EP3489242A4 (en) * 2016-07-22 2020-06-24 Medshine Discovery Inc. NITROIMIDAZOLE CRYSTAL AND SALT AND PRODUCTION METHOD THEREFOR
ES2899365T3 (es) 2017-08-16 2022-03-11 Glaxosmithkline Ip Dev Ltd Compuestos novedosos
CN112236141A (zh) 2018-06-11 2021-01-15 大塚制药株式会社 包含德拉马尼的组合物
CN109705022A (zh) * 2018-12-28 2019-05-03 上海彩迩文生化科技有限公司 一种芳香胺中间体的制备方法
CN112300192B (zh) * 2019-08-02 2023-08-11 南京长澳医药科技有限公司 硝基咪唑类化合物及其制备方法和用途
CN110483549B (zh) * 2019-08-30 2021-03-05 沈阳药科大学 一种硝基咪唑吡喃类抗结核药物的制备方法
CN110615800A (zh) * 2019-10-16 2019-12-27 李丽丽 硝基咪唑类化合物及其制备方法和用途
CN112156088B (zh) * 2020-10-30 2021-08-31 健民药业集团股份有限公司 一种化合物在制备结核分枝杆菌抑制剂中的用途
CN113603706A (zh) * 2021-08-04 2021-11-05 深圳市泰力生物医药有限公司 德拉马尼的晶型、含有该晶型的活性药物和药物组合物
WO2024024938A1 (ja) 2022-07-29 2024-02-01 大塚製薬株式会社 デラマニド含有固体分散体
CN115368252B (zh) * 2022-09-19 2024-01-12 西北农林科技大学 一种4-胺基酚类衍生物及应用
CN116640106B (zh) * 2023-05-11 2024-03-08 郑州大学 一种苯基哌嗪类化合物及其制备方法、应用
CN119059990B (zh) * 2024-11-01 2025-02-07 安徽昊帆生物有限公司 1-氨基甲酸叔丁酯哌嗪的制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997001562A1 (en) * 1995-06-26 1997-01-16 Pathogenesis Corporation Nitroimidazole antibacterial compounds and methods of use thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997001562A1 (en) * 1995-06-26 1997-01-16 Pathogenesis Corporation Nitroimidazole antibacterial compounds and methods of use thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101191072B1 (ko) 2007-05-08 2012-10-15 오쓰까 세이야꾸 가부시키가이샤 에폭시 화합물 및 이의 제조 방법

Also Published As

Publication number Publication date
AR091771A2 (es) 2015-02-25
MY139244A (en) 2009-09-30
EP2570418A2 (en) 2013-03-20
US20060094767A1 (en) 2006-05-04
CY2014041I2 (el) 2016-07-27
JP4186065B2 (ja) 2008-11-26
CN102532162A (zh) 2012-07-04
BE2014C053I2 (enExample) 2022-08-30
CY2014041I1 (el) 2016-07-27
EP2570418A3 (en) 2013-07-03
WO2004033463A1 (ja) 2004-04-22
PL409525A1 (pl) 2014-11-10
PT1555267E (pt) 2013-01-29
US7262212B2 (en) 2007-08-28
RU2005114017A (ru) 2006-01-20
EP1555267A1 (en) 2005-07-20
HUS1400046I1 (hu) 2017-04-28
DK1555267T3 (da) 2013-02-11
CA2497569A1 (en) 2004-04-22
ZA200501033B (en) 2006-06-28
RU2326121C3 (ru) 2021-09-17
SI1555267T1 (sl) 2013-05-31
CY1113578T1 (el) 2016-06-22
JP2004149527A (ja) 2004-05-27
KR20050061473A (ko) 2005-06-22
HK1085463A1 (zh) 2006-08-25
AR086485A2 (es) 2013-12-18
TWI347946B (en) 2011-09-01
PL376157A1 (en) 2005-12-27
ES2400179T3 (es) 2013-04-08
EP1555267A4 (en) 2010-08-18
PL404913A1 (pl) 2013-09-30
CA2497569C (en) 2011-05-24
UA83200C2 (en) 2008-06-25
MXPA05003674A (es) 2005-06-08
CN102532162B (zh) 2015-05-27
PL217919B1 (pl) 2014-09-30
AR041198A1 (es) 2005-05-04
AU2003272979B2 (en) 2009-07-23
LU92517I2 (fr) 2014-10-13
BRPI0314344B8 (pt) 2021-05-25
CN101255170A (zh) 2008-09-03
CN1705670A (zh) 2005-12-07
BR0314344A (pt) 2005-07-12
AU2003272979A1 (en) 2004-05-04
FR14C0066I2 (fr) 2015-05-22
EP1555267B1 (en) 2013-01-16
CN101172981A (zh) 2008-05-07
HK1171018A1 (en) 2013-03-15
RU2326121C2 (ru) 2008-06-10
CN100366624C (zh) 2008-02-06
AR089950A2 (es) 2014-10-01
BRPI0314344B1 (pt) 2019-11-26
TW200420568A (en) 2004-10-16
FR14C0066I1 (enExample) 2014-10-17

Similar Documents

Publication Publication Date Title
EP1555267B1 (en) 2,3-DIHYDRO-6-NITROIMIDAZO[2,1-b]OXAZOLES
JP4787529B2 (ja) 医薬組成物
RU2365593C2 (ru) ПРОИЗВОДНЫЕ 2,3-ДИГИДРО-6-НИТРОИМИДАЗО [2,1-b] ОКСАЗОЛА ДЛЯ ЛЕЧЕНИЯ ТУБЕРКУЛЕЗА
CN122036680A (zh) 抗纤维化吡啶酮类
CA2711655A1 (en) Condensed aminodihydrothiazine derivative
HUE032470T2 (en) Morphinan derivative
US20090318690A1 (en) Benzisoxazole Compound
JP5345174B2 (ja) 医薬組成物
JP4761756B2 (ja) ２，３−ジヒドロイミダゾ［２，１−ｂ］オキサゾ−ル化合物
HK1181049A (en) 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles compound
HK1120499A (en) 2,3-dihydro-6-nitroimidazo [2,1-b] oxazoles
HK1118543A (en) 2,3-dihydro-6-nitroimidazo (2,1-b) oxazoles
HK1171018B (en) 2,3-dihydro-6-nitroimidazo (2, 1-b) oxazoles
HK1085463B (en) 2,3-dihydro-6-nitroimidazo (2,1-b) oxazoles
MXPA06004064A (en) 2,3-dihydro-6-nitroimidazo (2,1-b) oxazole compounds for the treatment of tuberculosis

Legal Events

Date Code Title Description
A201 Request for examination
PA0105 International application

Patent event date: 20050317

Patent event code: PA01051R01D

Comment text: International Patent Application

PA0201 Request for examination
PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20060529

Patent event code: PE09021S01D

AMND Amendment
E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20061227

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20060529

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I

AMND Amendment
J201 Request for trial against refusal decision
PJ0201 Trial against decision of rejection

Patent event date: 20070126

Comment text: Request for Trial against Decision on Refusal

Patent event code: PJ02012R01D

Patent event date: 20061227

Comment text: Decision to Refuse Application

Patent event code: PJ02011S01I

Appeal kind category: Appeal against decision to decline refusal

Decision date: 20070308

Appeal identifier: 2007101001067

Request date: 20070126

PB0901 Examination by re-examination before a trial

Comment text: Amendment to Specification, etc.

Patent event date: 20070126

Patent event code: PB09011R02I

Comment text: Request for Trial against Decision on Refusal

Patent event date: 20070126

Patent event code: PB09011R01I

Comment text: Amendment to Specification, etc.

Patent event date: 20060829

Patent event code: PB09011R02I

B701 Decision to grant
PB0701 Decision of registration after re-examination before a trial

Patent event date: 20070308

Comment text: Decision to Grant Registration

Patent event code: PB07012S01D

Patent event date: 20070305

Comment text: Transfer of Trial File for Re-examination before a Trial

Patent event code: PB07011S01I

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20070525

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20070525

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20100512

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20110421

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20120507

Start annual number: 6

End annual number: 6

FPAY Annual fee payment

Payment date: 20130503

Year of fee payment: 7

PR1001 Payment of annual fee

Payment date: 20130503

Start annual number: 7

End annual number: 7

FPAY Annual fee payment

Payment date: 20140502

Year of fee payment: 8

PR1001 Payment of annual fee

Payment date: 20140502

Start annual number: 8

End annual number: 8

A101 Application to extend term of patent right by permit
PA0101 Application to register extension of term of patent right by permit, etc.

Patent event date: 20150122

Patent event code: PA01011R01D

Comment text: Application to Register Extension of Term of Patent Right by Permit, etc.

FPAY Annual fee payment

Payment date: 20150430

Year of fee payment: 9

PR1001 Payment of annual fee

Payment date: 20150430

Start annual number: 9

End annual number: 9

FPAY Annual fee payment

Payment date: 20160427

Year of fee payment: 10

PR1001 Payment of annual fee

Payment date: 20160427

Start annual number: 10

End annual number: 10

FPAY Annual fee payment

Payment date: 20170504

Year of fee payment: 11

PR1001 Payment of annual fee

Payment date: 20170504

Start annual number: 11

End annual number: 11

FPAY Annual fee payment

Payment date: 20180427

Year of fee payment: 12

PR1001 Payment of annual fee

Payment date: 20180427

Start annual number: 12

End annual number: 12

FPAY Annual fee payment

Payment date: 20190429

Year of fee payment: 13

PR1001 Payment of annual fee

Payment date: 20190429

Start annual number: 13

End annual number: 13

PR1001 Payment of annual fee

Payment date: 20210428

Start annual number: 15

End annual number: 15

PR1001 Payment of annual fee

Payment date: 20230418

Start annual number: 17

End annual number: 17